The global Hek293 Cell Line market is expanding as pharmaceutical companies, biotechnology firms, and research institutions invest in advanced cell culture technologies to support vaccine production, antibody development, and gene therapy applications. The market was valued at USD 7.32 billion in 2023 and is projected to reach USD 20.8 billion by 2032, growing at a CAGR of 12.31%. The Hek293...